Gregory Grunberg

Insider Reports History

Location
Waltham, MA
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Gregory Grunberg
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory Grunberg:

Form 4 holding Director

Kala Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
2,877,006
Estimated value
$19,391,020
Report date
17 Jun 2021
Price
$6.74
Ownership
By Longitude Venture Partners II, L.P.
Form 4 holding Director

Kala Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
2,534,854
Estimated value
$17,084,916
Report date
17 Jun 2021
Price
$6.74
Ownership
By Longitude Venture Partners IV, L.P.
Form 4 holding Director, 10%+ Owner

89bio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
27,400
Estimated value
Report date
09 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Gregory Grunberg

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .